Article
Upregulated ONECUT2 impeded the efficacy of 5-FU treatment to relapsed patients and might be an emerging indicator of chemotherapy in gastric cancer
2022-05-10
Abstract excerpt
<h4>Background: </h4> Chemotherapeutic resistance is a main obstacle for prolonging the lifetime of gastric cancer (GC) patients, so new emerging solutions still remain to be investigated. We aim to identify an effective target, ONECTU2, for chemotherapy of GC patient, particularly relapsed patients. <h4>Methods: </h4>: STAD patients matched with clinical features and transcriptome sequencing data from TCGA were u...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer Cells and Metastasis
- Cancer-related molecular mechanisms research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal Cancer Treatments and Studies
- Epigenetics and DNA Methylation
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
- Pancreatic and Hepatic Oncology Research
Identifiers and source
- Literature Corpus work
- 68e5b258-ac1a-5d4a-aeb0-8716e493a35f
- DOI
- 10.21203/rs.3.rs-1497914/v2
